2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
FDA Comment Number : EC1095
Submitter : Miss. Melanie Doherty Date & Time: 10/27/2005 12:10:20
Organization : SUNY Oswego Women's Center
Category : Academia
Issue Areas/Comments
GENERAL
GENERAL
The FDA has to stop dragging its feet on its decision on whether emergency contraception will be available over the counter or not. These constant delays are hurting women, who have to worry about carrying to term when they don't want to be pregnant or whether to have an abortion (which can be quite costly).

EC is most effective (95%) if taken within 24 hours after unprotected sexual intercourse - when a condom breaks, birth control is not used, or if a sexual assault occurs. Forcing women to get a prescription before they can obtain Plan B is an unwise and unnecessary burden on all women, especially poor women who may not have access to a physician. Moreover, requiring a physician's prescription increases the total cost of EC dramatically